MarginsXMarginsX
Home › Markets › Health Care › OPK

OPKO Health Inc. (OPK)

OPK trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.62
-3.57% on the day
Market cap
$1.2B
Small cap
Revenue · 2025
$606.9M
-14.9% on 2024
Net income · 2025
-$225.7M
-37.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/944809/000119312526076596/0001193125-26-076596-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerOPK on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000944809
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$606.9M
Net income-$225.7M
Operating income-$117.4M
Net margin-37.2%
Operating margin-19.3%
Revenue growth-14.9%
Cash$364.4M
Total assets$1.9B
P/E (computed)Net income was not positive
P/S (computed)2.0×

Warning signs

Cash runway
36.9 months
$384.0M cash at September 30, 2026
Share count, 1 year
-3.3%
2025-10-17 to 2026-10-20 · -4.0% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
$3.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$384.0M cash; operating cash flow -$31.3M a quarter.Report 2026-09-30
Shares outstanding742,506,477 (2026-10-20); 767,701,280 a year earlier; 773,056,533 three years earlier.Cover page 2026-10-20
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Miami, Florida, United StatesPCAOB Form AP 2026-03-23
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $3.2M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$65.4M-$53.5M-$36.3M$384.0M$477.4M$501.6M10-Q 2026-11-04
Q2 2026
2026-06-30
$163.6M-$8.4M-$43.5M$300.8M$349.1M$492.7M10-Q/A 2026-08-28
Q1 2026
2026-03-31
$124.2M-$54.8M-$19.3M$331.9M$345.7M$485.9M10-Q/A 2026-08-28
Q4 2025
2025-12-31
$148.5M-$31.3M-$25.9M$364.4M$344.0M$511.6M10-K 2026-02-26
Q3 2025
2025-09-30
$56.4M$21.6M-$34.6M$412.0M$344.2M$546.8M10-Q 2026-11-04
Q2 2025
2025-06-30
$156.8M-$148.4M-$83.4M$267.3M$343.3M$664.0M10-Q/A 2026-08-28
Q1 2025
2025-03-31
$150.0M-$67.6M-$34.6M$428.8M$439.2M$689.4M10-Q/A 2026-08-28
Q4 2024
2024-12-31
$183.6M$14.0M-$44.4M$426.6M$437.2M$713.1M10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52019-10-25
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-05-15

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-2.9%
1 month+27.3%
3 months+20.0%
Year to date+33.3%
1 year+31.3%
From 52-week high-5.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
KARDKardigan Inc.$12.85-7.02%$1.2B
OMEROmeros Corporation$16.68-4.63%$1.2B
SLNSilence Therapeutics Plc American Depository Share$19.80-0.15%$1.2B
CMPSCOMPASS Pathways Plc American Depository Shares$8.27-8.21%$1.2B
AAPGAscentage Pharma Group International American Depository Shares$13.29-9.10%$1.2B
AMPHAmphastar Pharmaceuticals Inc.$29.17-0.68%$1.2B
NKTRNektar Therapeutics$36.44-2.23%$1.2B
MNKDMannKind Corporation$3.96-4.24%$1.3B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier